Use the search parameters below to filter talks:

Calendar
Calendar

2012 - TTS International Congress (Berlin)

Immunosuppression - Immunosuppression in Renal Transplantation
16 July 2012  /  10:30 - 12:00

Low Rejection Rate and Optimal Renal Function in Kidney Transplantation from Elderly Donors with Everolimus and Tacrolimus Slow Release

Presenter: Lucrezia Furian, ,

- Low Rejection Rate and Optimal Renal Function in Kidney Transplantation from Elderly Donors with Everolimus and Tacrolimus Slow Release

Presenter: Lucrezia Furian, ,

A Prospective Randomized Trial Aimed to Reduce the Incidence of Cytomegalovirus (CMV) Infection in Kidney Transplant Recipients

Presenter: Helio Tedesco-Silva, ,

- A Prospective Randomized Trial Aimed to Reduce the Incidence of Cytomegalovirus (CMV) Infection in Kidney Transplant Recipients

Presenter: Helio Tedesco-Silva, ,

Reduced Frequency of Peripheral Th17-Precursors of the Phenotype CD4+CD161+ Following Kidney Transplantation and Long-Term Therapy with Belatacept

Presenter: Florian Vondran, ,

- Reduced Frequency of Peripheral Th17-Precursors of the Phenotype CD4+CD161+ Following Kidney Transplantation and Long-Term Therapy with Belatacept

Presenter: Florian Vondran, ,

Regulatory T Cell Function of Sotrastaurin Treated Kidney Transplant Patients

Presenter: Annelies de Weerd, ,

- Regulatory T Cell Function of Sotrastaurin Treated Kidney Transplant Patients

Presenter: Annelies de Weerd, ,

Histological Progression of Interstitial Fibrosis/Tubular Atrophy (IF/TA) According to Epithelial-Mesenchymal Transition (EMT) Profile: The CERTITEM Trial

Presenter: Alexandre Hertig, ,

- Histological Progression of Interstitial Fibrosis/Tubular Atrophy (IF/TA) According to Epithelial-Mesenchymal Transition (EMT) Profile: The CERTITEM Trial

Presenter: Alexandre Hertig, ,

Selection of Appropriate Composite Endpoints Is Critical for Assessing Efficacy Failure - Perspectives from the OSAKA Study

Presenter: Bernhard Banas, ,

- Selection of Appropriate Composite Endpoints Is Critical for Assessing Efficacy Failure - Perspectives from the OSAKA Study

Presenter: Bernhard Banas, ,

Kidney - Chronic Graft Injury in Kidney Transplantation I
16 July 2012  /  10:30 - 12:00

Anti-Angiotensin II Type 1-Receptor Antibodies Accelerate Late Renal Allograft Failure in the Absence or Presence of HLA Antibodies

Presenter: Nils Lachmann, ,

- Anti-Angiotensin II Type 1-Receptor Antibodies Accelerate Late Renal Allograft Failure in the Absence or Presence of HLA Antibodies

Presenter: Nils Lachmann, ,

Subclinical Antibody Mediated Allograft Rejection (AMR): Incidence in Protocol Biopsies (Pbx)

Presenter: Cinthia Drachenberg, ,

- Subclinical Antibody Mediated Allograft Rejection (AMR): Incidence in Protocol Biopsies (Pbx)

Presenter: Cinthia Drachenberg, ,

Mast Cell Quantitation in Renal Biopsies as a Potential Marker for the Cumulative Burden of Tissue Injury

Presenter: John Papadimitriou, ,

- Mast Cell Quantitation in Renal Biopsies as a Potential Marker for the Cumulative Burden of Tissue Injury

Presenter: John Papadimitriou, ,

Responses to Non-Polymorphic HLA Derived Peptides in a Prospective Study of Renal Transplant Recipients

Presenter: Seema Jham, ,

- Responses to Non-Polymorphic HLA Derived Peptides in a Prospective Study of Renal Transplant Recipients

Presenter: Seema Jham, ,

Cluster Analysis Shows that Chronic Damage in Early Indication Biopsies Predicts Long-Term Graft Survival, While Early Active Inflammation Does Not

Presenter: Maarten Naesens, ,

- Cluster Analysis Shows that Chronic Damage in Early Indication Biopsies Predicts Long-Term Graft Survival, While Early Active Inflammation Does Not

Presenter: Maarten Naesens, ,

Cluster Analysis Shows the Multifaceted Aspects of Microcirculation Inflammation and Chronic Antibody-Mediated Rejection in Early Indication Biopsies of Renal Allografts

Presenter: Maarten Naesens, ,

- Cluster Analysis Shows the Multifaceted Aspects of Microcirculation Inflammation and Chronic Antibody-Mediated Rejection in Early Indication Biopsies of Renal Allografts

Presenter: Maarten Naesens, ,

Recipients´ Smoking Habits and Death-Censored Renal Allograft Survival

Presenter: Yves Vanrenterghem, ,

- Recipients´ Smoking Habits and Death-Censored Renal Allograft Survival

Presenter: Yves Vanrenterghem, ,

Borderline Rejection Detected by Protocol Biopsy Negatively Impacts Graft Survival and Function

Presenter: Thomas Gonwa, ,

- Borderline Rejection Detected by Protocol Biopsy Negatively Impacts Graft Survival and Function

Presenter: Thomas Gonwa, ,

Kidney - Acute Graft Injury in Kidney Transplantation I
16 July 2012  /  10:30 - 12:00

Specific Diagnostic of Acute Renal Transplant Rejection by Application of 18F-FDG Labeled T-Lymphocytes in Rat

Presenter: Alexander Grabner, ,

- Specific Diagnostic of Acute Renal Transplant Rejection by Application of 18F-FDG Labeled T-Lymphocytes in Rat

Presenter: Alexander Grabner, ,

Pretransplant Frequencies of CD28nullCD2highNKG2D+ Memory T Cells Correlate with Acute Cellular Rejection (ACR)

Presenter: Opas Traitanon, ,

- Pretransplant Frequencies of CD28nullCD2highNKG2D+ Memory T Cells Correlate with Acute Cellular Rejection (ACR)

Presenter: Opas Traitanon, ,

Activated Tissue-Resident CD47 Is a Proximate Promoter of Renal Ischemia Reperfusion Injury

Presenter: Natasha Rogers, ,

- Activated Tissue-Resident CD47 Is a Proximate Promoter of Renal Ischemia Reperfusion Injury

Presenter: Natasha Rogers, ,

One Year Results Following Treatment of Acute Humoral Rejections in Kidney Transplant Recipients- a Single Center Experience

Presenter: Christina Dörje, ,

- One Year Results Following Treatment of Acute Humoral Rejections in Kidney Transplant Recipients- a Single Center Experience

Presenter: Christina Dörje, ,

Prevalence and Clinical Impact of Acute Rejection in Patients with Hepatitis C after Renal Transplantation in the Period 1990-2002 in Spain

Presenter: Jose Maria Morales, ,

- Prevalence and Clinical Impact of Acute Rejection in Patients with Hepatitis C after Renal Transplantation in the Period 1990-2002 in Spain

Presenter: Jose Maria Morales, ,

Non-HLA Antibodies Targeting G-Protein Coupled Receptors Induce mTORC1 and mTORC2 Signalling in Human Microvascular Endothelium

Presenter: Oskar Wischnewski, ,

- Non-HLA Antibodies Targeting G-Protein Coupled Receptors Induce mTORC1 and mTORC2 Signalling in Human Microvascular Endothelium

Presenter: Oskar Wischnewski, ,

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi